Hospital de Vilafranca
Vilafranca del Penedès, Barcelona, 08720, Spain
Location status: Recruiting
Location contact
Altea Pérez
PRINCIPAL_INVESTIGATOR
David Benaiges
PRINCIPAL_INVESTIGATOR
Noemí Casaponsa
CONTACT
+34 938960025 ext. 43197
NCT Number: NCT07285330
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Vilafranca del Penedès, Barcelona, 08720, Spain
Location status: Recruiting
Altea Pérez
PRINCIPAL_INVESTIGATOR
David Benaiges
PRINCIPAL_INVESTIGATOR
Noemí Casaponsa
CONTACT
+34 938960025 ext. 43197
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital
Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit
Time frame: three months after completion of the intervention
Glycated hemoglobin (HbA1c) levels three months after completion of the intervention
Contact information is provided by the study sponsor or research team.
Consorci Sanitari de l'Alt Penedès i Garraf
Other
NUTRI-DIAB: Impact of the Dietitian-Nutritionist Model vs. Day Hospital on the Metabolic Control of Patients With Type 2 Diabetes
Acronym: NUTRI-DIAB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07463209
Autoimmune Diseases, Diabetes (DM)
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07317310
Behavior, Body Weight
Taipei, Taiwan
View Trial DetailsNCT07702461
Atrophy, Behavior
Columbus, Ohio, United States
View Trial DetailsNCT07675161
Diabetes (DM), Diabetes (Insulin-requiring, Type 1 or Type 2)
Sacramento, California, United States
View Trial Details